Table 2.
25(OH)D subgroups | Control (n=40) | Nasal polyp (n=46) |
---|---|---|
Deficiency (≤20 ng/mL) | 35 (84.5%) | 40 (86.9%) |
Insufficiency (21–29 ng/mL) | 5 (12.5%) | 2 (4.4%) |
Normal (≥30 ng/mL) | 0 (0%) | 4 (8.9%) |
χ2=5.226; p=0.073. |
25(OH)D – 25 (OH) vitamin D.
25(OH)D subgroups | Control (n=40) | Nasal polyp (n=46) |
---|---|---|
Deficiency (≤20 ng/mL) | 35 (84.5%) | 40 (86.9%) |
Insufficiency (21–29 ng/mL) | 5 (12.5%) | 2 (4.4%) |
Normal (≥30 ng/mL) | 0 (0%) | 4 (8.9%) |
χ2=5.226; p=0.073. |
25(OH)D – 25 (OH) vitamin D.